Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
Byung‐Hak Kim(Catholic University of Korea), Sang‐Kyu Ye(Seoul National University)
Cited by 19
Related Papers
Interleukin-6 Induces S100A9 Expression in Colonic Epithelial Cells through STAT3 Activation in Experimental Ulcerative Colitis
|PLoS ONE|2012|91
Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron–Microglia Interactions
|Neuropsychopharmacology|2017|67
Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation<i>via</i>inhibition of JAK3/STAT3 signaling
|Experimental & Molecular Medicine|2011|37